Psyence Group Inc. (CSE: PSYG | OTCQB: PSYGF), a life science biotechnology company pioneering the use of natural psychedelics in mental health and well-being,...
The article Small Pharma Completes Enrollment in Phase IIa DMT Trial was originally published on Microdose. Small Pharma has started the week with some...
Core One Labs Inc. (CSE:COOL | OTCQB:CLABF | Frankfurt:LD6, WKN:A3CSSU) is pleased to announce that following the receipt of very positive results during...
After four years of optimistic funding fueled by strong research from top-tier universities, the novelty surrounding startups in the psychedelics market...
The article News You Might Have Missed: Sep 19th, 2022 was originally published on Microdose. Welcome to the News You Might Have Missed, a weekly...
A jump in research studies sparks increased educational programs. The post The Future Psychedelics Workforce is Getting Schooled Today appeared first on...
PharmaTher Holdings Ltd. (OTCQB: PHRRF | CSE: PHRM), a leader in specialty ketamine pharmaceuticals, today announced that the Phase 1/2 clinical Study...
Oral psilocybin film-strips to treat could conduct the first-in-human clinical study as soon as next year. The post Revive Therapeutics Gets Nod From FDA,...
Isolating the chemical structures driving the antidepressant and anxiolytic effects of psychedelics may be used as lead structures to identify next-generation...
Traditional psychedelics have shown great potential for treating issues like depression, anxiety, PTSD, and addiction. Psilocybin and MDMA will likely...